Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation
Rhea-AI Summary
Splash Beverage Group (NYSE American: SBEV) announced two major steps to advance its NYSE American compliance plan and strengthen its balance sheet. The company settled approximately $3.3 million of legacy accounts payable and accrued liabilities for about $550,000 in cash, expecting an approximate $2.75 million gain from extinguishment of indebtedness, subject to final accounting review. The settlements are expected to remove roughly 84% of the negotiated obligations while paying about 17% of their face value.
The board also approved a 1-for-4 reverse stock split of common shares. Outstanding shares will be reduced from about 25.2 million to 6.3 million, and authorized shares from 400 million to 100 million. No fractional shares will be issued; fractions will be rounded down to the nearest whole share. The split becomes effective after market close on July 24, 2026, with post-split trading starting July 27, 2026 under the symbol SBEV with new CUSIP 84862C401. According to Splash Beverage, the reverse split is intended to help maintain compliance with NYSE American minimum share price requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- $3.3 million of legacy liabilities settled for about $550,000 cash
- Expected gain on debt extinguishment of approximately $2.75 million, pending review
- Liability settlements eliminate about 84% of negotiated obligations
- Reverse split supports NYSE American minimum share price compliance plan
- Outstanding shares reduced from 25.2 million to about 6.3 million
- Authorized shares cut from 400 million to 100 million
Negative
- 1-for-4 reverse stock split consolidates existing shareholdings
- Fractional post-split shares rounded down, slightly reducing some holders’ share counts
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 09 | Compliance plan accepted | Positive | -5.0% | NYSE American accepted a compliance plan, granting time to regain listing standards. |
| Jul 07 | CannEpil license terms | Positive | -23.2% | Detailed 20-year global CannEpil license with royalties and strategic investment. |
| Jul 06 | CannEpil rights deal | Positive | +42.5% | Announced exclusive global CannEpil rights and financing structure for development. |
| Jun 15 | Avicanna investment | Positive | +0.1% | Completed CDN$300,000 strategic investment in cannabinoid biopharma Avicanna. |
| Jun 03 | Compliance and going concern | Negative | +71.0% | Corporate update on NYSE compliance process and going concern disclosure. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent headlines tied to compliance and strategic cannabinoid deals have often driven large, sometimes contrary price moves, with several seemingly positive updates followed by negative reactions.
Key Terms
reverse stock split financial
cusip financial
equity incentive plans financial
stockholders' equity financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash," "Splash Beverage" or the "Company") today announced two significant actions designed to strengthen the Company's financial position and advance its previously announced NYSE American compliance plan.
The Company has successfully negotiated settlements with multiple legacy creditors representing approximately
In addition, the Company's Board of Directors has approved a 1-for-4 reverse stock split of the Company's issued and outstanding common stock. The details of the reverse stock split are described below.
The reverse stock split is intended to support the Company's continued compliance with NYSE American's minimum share price requirements and forms an important component of the Company's previously announced Exchange-approved compliance plan.
Brady Cobb, Interim Chief Executive Officer, commented: "Today's announcement reflects continued execution against the strategic and financial roadmap we presented to both our shareholders and the NYSE American. In just the past few months, we have secured acceptance of our NYSE compliance plan, strengthened our liquidity through our effective equity line registration, substantially improved our balance sheet through negotiated settlements with legacy creditors, completed our strategic investment in Avicanna, acquired the exclusive worldwide licensing rights to CannEpil®, and continue advancing additional initiatives designed to create long-term shareholder value."
"Negotiating approximately
Reverse Stock Split Supports Continued NYSE American Listing
The Company's Board of Directors has approved a 1-for-4 reverse stock split of the Company's issued and outstanding common stock.
Upon effectiveness:
- Every four issued and outstanding shares of the Company's common stock will automatically combine into one share of common stock.
- Appropriate proportional adjustments will be made to outstanding stock options, warrants, restricted stock units, preferred stock conversion ratios, and shares reserved under the Company's equity incentive plans.
- No fractional shares will be issued as a result of the reverse stock split. Instead, all fractional shares will be rounded down to the nearest whole share.
- The number of shares of common stock outstanding will be reduced from approximately 25.2 million shares to approximately 6.3 million shares.
- The number of shares of common stock authorized under the Company’s articles of incorporation will be reduced from 400 million shares to 100 million shares.
- The Company's common stock will continue trading on the NYSE American under the symbol "SBEV" and will receive a new CUSIP number of 84862C401.
The reverse stock split will be effective after the market closes on July 24, 2026 following the filing and effectiveness of an amendment to the Company's articles of incorporation, with the common stock trading on a post-split basis when the market opens on July 27, 2026.
The reverse stock split is intended to support the Company's continued compliance with NYSE American's minimum share price requirements and is a key component of the Company's previously announced compliance plan accepted by the Exchange.
"The reverse stock split is an important corporate action supporting our broader compliance strategy," Cobb continued. "While a reverse stock split does not change the underlying value of the Company, maintaining our NYSE American listing is critically important as we continue strengthening our balance sheet and executing our compliance plan. We believe preserving our national exchange listing enhances our visibility, credibility, liquidity, and ability to attract a broader universe of institutional and retail investors."
"Our focus remains disciplined execution. We intend to continue improving the Company's financial position, achieving full compliance with NYSE American's listing standards as expeditiously as possible, and creating sustainable long-term value for our shareholders."
About Splash Beverage Group, Inc.
Splash Beverage Group, Inc. (NYSE American: SBEV) is a publicly traded company headquartered in Fort Lauderdale, Florida. The Company is pursuing a strategic transformation toward becoming a cannabinoid health, wellness, and biopharmaceutical platform through disciplined capital allocation, strategic investments, acquisitions, and other platform-building initiatives.
More Information
Contact Information
Splash Beverage Group
Info@SplashBeverageGroup.com
Media Contact
Angela Gorman
AMWPR
angela@amwpr.com
917-348-0083
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s efforts towards balance sheet improvement, an anticipated
Forward-looking statements are based on current expectations and assumptions regarding the Company’s business and future conditions and are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Actual results may differ materially from those contemplated by such forward-looking statements due to a variety of factors, including, without limitation, the possibility that our efforts and strategic initiatives we pursue do not yield the benefits anticipated or sought, the possibility that projections and expectations with respect to our future operations and financial results prove to be incorrect including with respect to the anticipated
Additional information concerning these and other risk factors is contained in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025 and the Final Prospectus on Form 424B3 filed on June 26, 2026. Any forward-looking statement made by the Company speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments, or otherwise, except as required by law.